The PTAB Cancelled Claims, Not a Royalty Stream

The Patent Trial and Appeal Board ruled Wednesday that the challenged claims of U.S. Patent 8,984,228 are unpatentable as obvious. Bloomberg Law reported the decision Thursday. Daedalus Prime LLC bought the patent from Intel in 2022. Its title is a common caching agent for processor cores and an integrated I/O module. Arm Ltd. and MediaTek Inc. were the petitioners in IPR2025-00207.

The dominant copy is a victory lap: Arm knocked out an Intel-origin chip patent, so the cost of monetizing disputed semiconductor claims just went up. That sentence fuses a validity order with a licensing market. If the ruling materially raised the cost of monetizing those patents, the public file should show it in revenue, legal expense, a settlement, or a renegotiated term. It does not.

A §318(a) order is not a royalty line

The petition, filed December 13, 2024, asked the Board to cancel claims 1–7, 11–14, and 16–19. Claims 8–10 and 15 were not in that request. The asserted grounds were obviousness over prior art the petition named Agarwal, Sinharoy, Blumrich, and Sistla. Bloomberg’s account of Wednesday’s decision tracks that theory: two prior applications, an issued patent, and a scientific journal. A final written decision under 35 U.S.C. §318(a) can cancel challenged claims. It does not, by itself, reprice a license book.

The path to the hearing was procedural before it was technical. Then-Acting Director Coke Morgan Stewart denied institution on May 16, 2025, citing a related Eastern District of Texas case, Daedalus Prime LLC v. MediaTek, No. 2:24-cv-00235, then set for trial. MediaTek and Daedalus moved to stay pending settlement on May 15. The court dismissed that case with prejudice on May 22. Arm was not a party. On August 6, 2025, Director Review vacated the denial and sent the petition back, noting that IPR2023-01344 had already found unpatentable “substantially identical claims” in the child patent, U.S. 9,575,895 — a January 24, 2025 decision on a Mercedes petition. Wednesday’s order is the parent catching up to a family the Board had already cut.

That chronology matters for the monetization claim. The Texas suit that could have produced a public damages number, or at least a visible settlement, ended sixteen months before this final written decision. The dismissal is with prejudice. The terms are not on the docket. Treating Wednesday as the event that raised enforcement cost skips the case that actually settled.

Cancellation can still change a patent owner’s options. Surviving claims can be asserted. The owner can appeal to the Federal Circuit. Parallel suits can continue on other patents. Licensees can reopen terms if a contract says they may. Each of those is a mechanism. Each needs a document that ties this patent’s cancelled claims to a live royalty, a legal-spend line, or a deal. Daedalus Prime is a private LLC. Arm’s public disclosures this week do not quantify the ruling. No licensee 8-K in the search file does either.

Custom silicon is already a fight over who captures the die. Nvidia’s print can be shrugged while the stack still sells. Efficiency claims out of China and TSMC’s capex are supply and architecture. They are not a PTAB certificate. What still gets mis-priced is folding a claim cancellation into Arm’s licensing franchise, or into a general tax on chip-patent assertion, before anyone files a number.

The test is dated and small. An Arm, Daedalus, or licensee filing that quantifies licensing revenue, patent valuation, legal cost, or settlement terms as a result of IPR2025-00207 would collapse the residual. A Federal Circuit mandate, or a certificate cancelling the unchallenged claims as well, would widen the validity event. Until then, Alexandria cancelled a set of claims. It did not print a royalty.